@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-GZVMTVKK-D
  mesh:allowableQualifier jvr:-BT300B3G-Q, jvr:-TJHVZCRZ-0, jvr:-FWD2BGQ0-9, jvr:-SBNWSM1T-R, jvr:-G30ZJ446-J, jvr:-W6SQV79N-S, jvr:-HQRFT0C6-B, jvr:-XV06LPML-W, jvr:-D0F21513-5, jvr:-NB0XHT3S-N, jvr:-NHL3D2X0-S, jvr:-G4R176S9-J, jvr:-L6C0XPHT-4, jvr:-CB30NGKB-3, jvr:-T9HQD7ST-J, jvr:-R0ZCQ8X6-J, jvr:-THHNVC7V-3, jvr:-Q3979798-W, jvr:-H7K65Q8S-Z, jvr:-NKM836P1-M, jvr:-M63HSDM7-1, jvr:-R3QWLHRG-V, jvr:-NFTHND7Q-8, jvr:-WK5F724J-1, jvr:-S0CS1X5R-5 ;
  skos:hiddenLabel "Mésilate de piribédil"@fr, "ET-495"@fr, "ET-495"@en, "Mésylate de piribédil"@fr, "Trivastal"@en, "Piribedil Mesylate"@en, "Chlorhydrate de piribédil"@fr, "ET495"@fr, "EU-4200"@fr, "EU-4200"@en, "EU4200"@fr, "Piribedil Mono-hydrochloride"@en, "Piribedil Hydrochloride"@en ;
  skos:altLabel "52293-23-9 (mesylate)"@fr, "Pyrimidine, 2-(4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl)-"@fr, "Pyrimidine, 2-(4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl)-"@en, "52293-23-9 (mesylate)"@en, "69239-66-3 (HCl)"@fr, "69239-66-3 (HCl)"@en, "3605-01-4 (Piribedil)"@en, "3605-01-4 (Piribedil)"@fr, "78213-63-5 (mono-HCl)"@fr, "78213-63-5 (mono-HCl)"@en, "DO22K1PRDJ"@fr, "DO22K1PRDJ"@en, "Piribendyl"@en ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D010891> ;
  skos:broader jvr:-ZSFBN4K6-W ;
  skos:definition "A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist."@en ;
  a skos:Concept, mesh:Descriptor ;
  dc:created "1974-11-19"^^xsd:date ;
  skos:inScheme jvr: ;
  dc:modified "2016-05-31"^^xsd:date ;
  mesh:pharmacologicalAction jvr:-M4W33FZ9-8, jvr:-C9JFSVWC-Q ;
  skos:prefLabel "Piribédil"@fr, "Piribedil"@en ;
  dc:established "1991-01-01"^^xsd:date .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-C9JFSVWC-Q
  skos:prefLabel "Agonistes de la dopamine"@fr, "Dopamine Agonists"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-ZSFBN4K6-W
  skos:prefLabel "Piperazines"@en, "Pipérazines"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-GZVMTVKK-D .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-M4W33FZ9-8
  skos:prefLabel "Antiparkinson Agents"@en, "Antiparkinsoniens"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .